OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells presents a paramount challenge for the biopharmaceutical industry. Multiple strategies can be employed enhance antibody titer, including process parameter optimization, genetic engineering, and the use of perfusion systems. Fine-tuning media composition p